Literature DB >> 27826066

Plant polyphenols as natural drugs for the management of Down syndrome and related disorders.

Rosa Anna Vacca1, Daniela Valenti2, Salvatore Caccamese3, Maria Daglia4, Nady Braidy5, Seyed Mohammad Nabavi6.   

Abstract

Polyphenols are secondary metabolites of plants largely found in fruits, vegetables, cereals and beverages, and therefore represent important constituents of the human diet. Increasing studies have demonstrated the potential beneficial effects of polyphenols on human health. Extensive reviews have discussed the protective effects of polyphenols against a series of diseases such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders. Limited studies have investigated the potential therapeutic effects of these natural compounds on neurodevelopmental disorders associated with intellectual disability, such as Down syndrome (DS), for which mitochondrial dysfunctions and oxidative stress are hallmarks and contribute to the deleterious symptoms and cognitive decline. This review, starting from the structure, source, bioavailability and pharmacokinetics of relevant polyphenols, highlights recent studies on the effect and potential molecular mechanism(s) of action of the phenolic compounds epigallocatechin-3-gallate, resveratrol and hydroxytyrosol in restoring mitochondrial energy deficit and in reversing phenotypical alteration in DS. The clinical implications of plant polyphenol dietary supplements as therapeutic tools in managing DS and other intellectual disability-related diseases, is also discussed. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Down syndrome; EGCG; Hydroxytyrosol; Intellectual disability; Mitochondria; Neurodevelopment diseases; Neuroprotection; Oxidative stress; Polyphenols; Resveratrol

Mesh:

Substances:

Year:  2016        PMID: 27826066     DOI: 10.1016/j.neubiorev.2016.10.023

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  8 in total

1.  Usage of and attitudes about green tea extract and Epigallocathechin-3-gallate (EGCG) as a therapy in individuals with Down syndrome.

Authors:  Rachel Long; Montana L Drawbaugh; Charlene M Davis; Charles R Goodlett; Jane R Williams; Randall J Roper
Journal:  Complement Ther Med       Date:  2019-07-02       Impact factor: 2.446

Review 2.  Anticancer Activities of Marine-Derived Phenolic Compounds and Their Derivatives.

Authors:  Dario Matulja; Filip Vranješević; Maria Kolympadi Markovic; Sandra Kraljević Pavelić; Dean Marković
Journal:  Molecules       Date:  2022-02-21       Impact factor: 4.411

3.  Caesalpinia Crista Linn. Induces Protection against DNA and Membrane Damage.

Authors:  R Sunil Kumar; Ramesh Balenahalli Narasingappa; Chandrashekhar G Joshi; Talakatta K Girish; Ananda Danagoudar
Journal:  Pharmacogn Mag       Date:  2017-07-11       Impact factor: 1.085

Review 4.  Natural products, PGC-1 α , and Duchenne muscular dystrophy.

Authors:  Ipek Suntar; Antoni Sureda; Tarun Belwal; Ana Sanches Silva; Rosa Anna Vacca; Devesh Tewari; Eduardo Sobarzo-Sánchez; Seyed Fazel Nabavi; Samira Shirooie; Ahmad Reza Dehpour; Suowen Xu; Bahman Yousefi; Maryam Majidinia; Maria Daglia; Giuseppe D'Antona; Seyed Mohammad Nabavi
Journal:  Acta Pharm Sin B       Date:  2020-01-08       Impact factor: 11.413

5.  S-Adenosylmethionine May Mitigate Obstructive Sleep Apnea in an Adult with Down Syndrome: A Case Report.

Authors:  Silvano Dragonieri; Giovanna Elisiana Carpagnano; Salvatore Caccamese
Journal:  Nat Sci Sleep       Date:  2022-02-04

Review 6.  Science and Healthy Meals in the World: Nutritional Epigenomics and Nutrigenetics of the Mediterranean Diet.

Authors:  Fabio Caradonna; Ornella Consiglio; Claudio Luparello; Carla Gentile
Journal:  Nutrients       Date:  2020-06-11       Impact factor: 5.717

7.  Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F0F1-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and Efficacy.

Authors:  Iris Scala; Daniela Valenti; Valentina Scotto D'Aniello; Maria Marino; Maria Pia Riccio; Carmela Bravaccio; Rosa Anna Vacca; Pietro Strisciuglio
Journal:  Antioxidants (Basel)       Date:  2021-03-16

8.  Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone.

Authors:  Daniela Valenti; Fiorenza Stagni; Marco Emili; Sandra Guidi; Renata Bartesaghi; Rosa Anna Vacca
Journal:  Antioxidants (Basel)       Date:  2021-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.